Phase II study on combination of capecitabine and oxaliplatin in patients with relapsed or refractory gastric cancer
Phase of Trial: Phase II
Latest Information Update: 25 May 2010
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 29 Jan 2010 Planned end date changed from 1 Dec 2009 to 1 Feb 2010 as reported by ClinicalTrials.gov record.
- 29 Jan 2010 Status changed from recruiting to suspended as reported by ClinicalTrials.gov record.
- 24 Dec 2007 New trial record.